IRIS
STRIPPOLI, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.343
EU - Europa 1.071
AS - Asia 850
OC - Oceania 13
AF - Africa 5
SA - Sud America 5
Totale 16.287
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.330
CN - Cina 689
SE - Svezia 453
GB - Regno Unito 168
IT - Italia 80
DE - Germania 78
SG - Singapore 63
UA - Ucraina 60
BE - Belgio 55
IN - India 46
FI - Finlandia 42
FR - Francia 28
IE - Irlanda 25
NL - Olanda 15
IL - Israele 14
AU - Australia 13
CA - Canada 8
ES - Italia 7
JP - Giappone 7
CZ - Repubblica Ceca 6
HK - Hong Kong 6
RO - Romania 6
VN - Vietnam 6
CH - Svizzera 5
HU - Ungheria 5
ME - Montenegro 4
BG - Bulgaria 3
MK - Macedonia 3
PA - Panama 3
RS - Serbia 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
CO - Colombia 2
DK - Danimarca 2
EC - Ecuador 2
HR - Croazia 2
IM - Isola di Man 2
IR - Iran 2
LT - Lituania 2
MA - Marocco 2
MY - Malesia 2
NO - Norvegia 2
PH - Filippine 2
PL - Polonia 2
PT - Portogallo 2
RU - Federazione Russa 2
SA - Arabia Saudita 2
TH - Thailandia 2
AL - Albania 1
BN - Brunei Darussalam 1
BR - Brasile 1
BS - Bahamas 1
CR - Costa Rica 1
EG - Egitto 1
GE - Georgia 1
GR - Grecia 1
LU - Lussemburgo 1
MD - Moldavia 1
MT - Malta 1
NG - Nigeria 1
NP - Nepal 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 16.287
Salva come PNG Salva come JPEG
Città #
Fairfield 2.688
Chandler 1.506
Woodbridge 1.363
Ashburn 1.318
Houston 1.166
Seattle 1.130
Cambridge 1.120
Wilmington 873
Ann Arbor 408
Nyköping 376
Beijing 308
Lawrence 289
Roxbury 285
Des Moines 204
Jacksonville 147
New York 119
San Diego 113
Inglewood 105
Dearborn 96
Nanjing 64
Brussels 55
Falls Church 46
Los Angeles 43
Washington 42
Singapore 40
London 39
Pune 33
Hefei 27
Boardman 25
Dublin 25
Edinburgh 25
Princeton 24
Bari 22
Guangzhou 22
Kunming 22
Brooklyn 18
Hebei 18
Nanchang 18
Jinan 17
Paris 17
Redwood City 17
Kilburn 16
Munich 16
Changsha 14
Jiaxing 14
Hounslow 13
Wuhan 13
Amsterdam 12
Shenyang 12
Hadera 11
Helsinki 11
Chicago 10
Stockholm 9
Prescot 8
Rome 8
San Francisco 8
San Mateo 8
Shanghai 8
Zhengzhou 8
Tianjin 7
Tokyo 7
Dong Ket 6
Madrid 6
Prague 6
Atlanta 5
Augusta 5
Jinhua 5
Milan 5
New Bedfont 5
New Delhi 5
Sydney 5
Toronto 5
Wandsworth 5
Budapest 4
Chengdu 4
Hong Kong 4
Norwalk 4
Podgorica 4
Rockhampton 4
Santa Clara 4
Xian 4
Acton 3
Auburn Hills 3
Belgrade 3
Chongqing 3
Frankfurt am Main 3
Hangzhou 3
Islington 3
Las Vegas 3
Marseille 3
Messina 3
Miami 3
Panama City 3
Sofia 3
Taichung 3
Tel Aviv 3
Teramo 3
Zurich 3
Altamura 2
Bangkok 2
Totale 14.636
Salva come PNG Salva come JPEG
Nome #
The Long-Term Impact of Renin-Angiotensin System (RAS) Inhibition on Cardiorenal Outcomes (LIRICO): A Randomized, Controlled Trial 143
A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study 141
Catheter-related interventions to prevent peritonitis in peritoneal dialysis: A systematic review of randomized, controlled trials 131
Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop 123
An "evidence-based" survey of therapeutic options for IgA nephropathy: assessment and criticism 113
Chromoendoscopy for Surveillance in Ulcerative Colitis and Crohn's Disease: A Systematic Review of Randomized Trials 108
HMG CoA reductase inhibitors (statins) for kidney transplant recipients 107
Prevalence and correlates of erectile dysfunction in men on chronic haemodialysis: a multinational cross-sectional study 104
Systematic review with network meta-analysis: endoscopic techniques for dysplasia surveillance in inflammatory bowel disease 103
Aldosterone Antagonists for Preventing the Progression of Chronic Kidney Disease: A Systematic Review and Meta-analysis 97
Addition of the Multidimensional Prognostic Index to the Estimated Glomerular Filtration Rate Improves Prediction of Long-Term All-Cause Mortality in Older Patients with Chronic Kidney Disease 94
Hemoglobin targets for the anemia of chronic kidney disease: a meta-analysis of randomized, controlled trials 91
How to read critically a prognostic cohort study 90
Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease 89
Induction and maintenance treatment of proliferative lupus nephritis: A meta-analysis of randomized controlled trials 88
Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in patients with micro- and macroalbuminuria and other cardiovascular risk factors: a systematic review of randomized controlled trials 88
Primary cerebral lymphoma and membranous nephropathy: a still unreported association 87
Clinician beliefs and attitudes about home haemodialysis: A multinational interview study 87
Prevalence and Correlates of Self-Reported Sexual Dysfunction in CKD: A Meta-analysis of Observational Studies 87
Proteinuria: Does vitamin D treatment improve outcomes in CKD? 87
Antihypertensive agents for preventing diabetic kidney disease 86
IgA Nephropathy: A Disease in Search of a Large-Scale Clinical Trial to Reliably Inform Practice 86
null 85
Phosphate-Binding Agents in Adults With CKD: A Network Meta-analysis of Randomized Trials 84
Aldosterone antagonists for preventing the progression of chronic kidney disease 84
Depression and sexual dysfunction in chronic kidney disease: a narrative review of the evidence in areas of significant unmet need 84
Current structure and organization for renal patient assistance in Italy 83
Aldosterone antagonists for preventing the progression of chronic kidney disease 83
Fluid intake and all-cause mortality, cardiovascular mortality and kidney function: A population-based longitudinal cohort study 83
Role of statins in preventing adverse cardiovascular outcomes in patients with chronic kidney disease 83
Mesalazine for people with diverticular disease: A systematic review of randomized controlled trials 82
Early markers of tubular dysfunction in antiretroviral-experienced HIV-infected patients treated with tenofovir versus abacavir 81
null 80
Antiplatelet agents for chronic kidney disease 80
Sunset for Statins after AURORA? 79
Antimicrobial agents to prevent peritonitis in peritoneal dialysis: A systematic review of randomized controlled trials 79
null 79
Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: A network meta-analysis 79
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients 79
Associations between hemodialysis access type and clinical outcomes: A systematic review 79
Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients 79
Oral disease in adults treated with hemodialysis: prevalence, predictors, and association with mortality and adverse cardiovascular events: the rationale and design of the ORAL Diseases in hemodialysis (ORAL-D) study, a prospective, multinational, longitudinal, observational, cohort study. 78
Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials 78
Quality of reporting of randomization methodology in nephrology trials 76
Antihypertensive agents for preventing diabetic kidney disease 75
Pre-emptive treatment for cytomegalovirus viremia to prevent cytomegalovirus disease in solid organ transplant recipients 74
Treatment for peritoneal dialysis-associated peritonitis 74
Predictors of bleeding complications in percutaneous ultrasound-guided renal biopsy 73
Antiplatelet therapy to prevent hemodialysis vascular access failure: Systematic review and meta-analysis 73
null 72
KHA-CARI commentary on the KDIGO clinical practice guideline for lipid management in chronic kidney disease 72
Immunosuppressive treatments for immunoglobulin A nephropathy: A meta-analysis of randomized controlled trials 72
Impact of icodextrin on clinical outcomes in peritoneal dialysis: A systematic review of randomized controlled trials 72
Oral mucosal lesions and risk of all-cause and cardiovascular mortality in people treated with long-term haemodialysis: The ORAL-D multinational cohort study 71
Home versus in-centre haemodialysis for end-stage kidney disease 71
HMG CoA reductase inhibitors (statins) for kidney transplant recipients 71
Serum testosterone levels and clinical outcomes in male hemodialysis patients 71
Correlation of Treatment Time and Ultrafiltration Rate with Serum Albumin and C-Reactive Protein Levels in Patients with End-Stage Kidney Disease Receiving Chronic Maintenance Hemodialysis: A Cross-Sectional Study 70
HMG CoA reductase inhibitors (statins) for dialysis patients 70
Darbepoetin for the anaemia of chronic kidney disease 70
Sexual Dysfunction in Women with ESRD Requiring Hemodialysis 69
Proteinuria and Clinical Outcomes in Hypertensive Patients 69
Vitamin D compounds for people with chronic kidney disease not requiring dialysis 69
Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients 69
Sevelamer: a promising but unproven drug 69
Vitamin D compounds for people with chronic kidney disease requiring dialysis 68
Antihypertensive agents for primary prevention of diabetic nephropathy 68
Prevalence and severity of oral disease in adults with chronic kidney disease: a systematic review of observational studies. 68
Biocompatible dialysis fluids for peritoneal dialysis 68
The impact of neutral-pH peritoneal dialysates with reduced glucose degradation products on clinical outcomes in peritoneal dialysis patients 68
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients 68
Haemoglobin targets: we were wrong, time to move on 67
How to conduct a randomized trial 67
Robotic Versus Laparoscopic Minimally Invasive Surgery for Rectal Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials 67
Non-immunosuppressive treatment for IgA nephropathy 67
The beliefs and expectations of patients and caregivers about home haemodialysis: An interview study 67
Meta-analysis: Vitamin D compounds in chronic kidney disease 67
The Italian experience of the national registry of renal biopsies 66
null 66
Protocol of the Long-term Impact of RAS Inhibition on Cardiorenal Outcomes (LIRICO) randomized trial 65
null 65
Benefits and Harms of Phosphate Binders in CKD: A Systematic Review of Randomized Controlled Trials 65
Calcimimetics and other simple pharmacological interventions do not work in dialysis: What can we do about it? 65
Thyroid hormones for acute kidney injury 65
null 65
Identifying patients at risk for microalbuminuria via interaction of the components of the metabolic syndrome: A cross-sectional analytic study 64
null 64
Healthy dietary patterns and risk of mortality and ESRD in CKD: A meta-analysis of cohort studies 64
Patients' perspectives on hemodialysis vascular access: A systematic review of qualitative studies 64
Risk of death following kidney allograft failure: A systematic review and meta-analysis of cohort studies 64
Effects of intensive blood pressure lowering on the progression of chronic kidney disease: A systematic review and meta-analysis 64
null 63
Patient satisfaction with in-centre haemodialysis care: An International Survey 63
Meta-analysis: Erythropoiesis-Stimulating Agents in Patients With Chronic Kidney Disease 62
Treatment for peritoneal dialysis-associated peritonitis 62
null 61
null 61
null 61
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis 61
A pegylated epoetin in anaemia of renal disease: non-inferiority for an unvalidated surrogate 60
Totale 7.773
Salva come PNG Salva come JPEG
Categoria #
all - tutte 73.665
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.665
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206.737 0 41 178 1.249 859 635 771 960 948 531 273 292
2020/20212.944 120 475 153 383 317 155 113 390 79 426 146 187
2021/20222.363 184 347 18 71 111 152 116 84 123 115 176 866
2022/20233.021 432 345 276 296 254 322 23 429 433 19 138 54
2023/20241.091 80 181 75 28 102 295 30 125 18 28 13 116
2024/202589 41 48 0 0 0 0 0 0 0 0 0 0
Totale 16.817